Larimar Therapeutics Inc

NASDAQ:LRMR   3:59:50 PM EDT
9.54
+0.16 (+1.71%)
Earnings Announcements

Larimar Therapeutics Reports Q3 Loss Per Share $0.92

Published: 11/12/2021 12:36 GMT
Larimar Therapeutics Inc (LRMR) - Larimar Therapeutics Reports Third Quarter 2021 Operating and Financial Results.
Q3 Loss per Share $0.92.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.72

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.71

More details on our Analysts Page.